Evidence map›Paper›PMID 40182998›Full record

ArticleBJR case reports2025

CT-like MR images to assess changes after radiotherapy for bone metastasis: a case report.

Osamu Tanaka, Takuya Taniguchi, Takuji Kiryu, Ryoshu Maejima, Chiyoko Makita, Masayuki Matsuo

Abstract readCase Reports
In one paragraph

Article in BJR case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Osamu TanakaDepartment of Radiation Oncology, Asahi University Hospital, Gifu 500-8523, Japan.ORCID https://orcid.org/0000-0002-7189-8407
Takuya TaniguchiDepartment of Radiation Oncology, Asahi University Hospital, Gifu 500-8523, Japan.
Takuji KiryuDepartment of Radiology, Asahi University Hospital, Gifu 500-8523, Japan.
Ryoshu MaejimaDepartment of Radiation Oncology, Asahi University Hospital, Gifu 500-8523, Japan.
Chiyoko MakitaDepartment of Radiation Oncology, Gifu University Hospital, Gifu 501-1194, Japan.
Masayuki MatsuoDepartment of Radiation Oncology, Gifu University Hospital, Gifu 501-1194, Japan.ORCID https://orcid.org/0000-0001-7615-3247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Setting the echo time to zero allows for the acquisition of bone images that were otherwise difficult to obtain with conventional MRI and clear visualization of CT-like MR images. This technique is mainly useful for detecting compression fractures; however, studies examining bone tumours have been lacking. Furthermore, no reports to date have investigated the usefulness of MRI for evaluating images before and after radiotherapy (RT) for bone tumours. Therefore, plain CT and MRI (T1/T2-weighted image and CT-like MRI) were performed under the same conditions before and after radiation therapy (RT) and examined the obtained images. An 86-year-old man received RT (30 Gy/3 fraction) for painful lumbar metastasis from prostate cancer. At 2 months after RT, no changes in T2-weighted images and plain CT scans were noted, but CT-like MRI showed an increase in the signal inside the bone metastasis. Examining how the images change over time is imperative given the difficulty of predicting the duration of the pain relief effects of RT for bone metastases. Therefore, the current case report explored whether combining various modalities, such as CT and MRI, could predict prognosis. We highlight the importance of investigating whether signal changes are correlated with pain symptoms and whether MRI can be a predictor.

Indexed as

bone metastasisMRIradiotherapy

Identifiers

PMID40182998
PMCPMC11968173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.